Nautilus Biotechnology, Inc.·4

Nov 10, 9:29 PM ET

Suzuki Kentaro 4

4 · Nautilus Biotechnology, Inc. · Filed Nov 10, 2025

Insider Transaction Report

Form 4
Period: 2025-11-06
Suzuki Kentaro
Chief Marketing Officer
Transactions
  • Purchase

    Common Stock

    2025-11-06$1.49/sh+4,000$5,9604,000 total

Documents

1 file
  • 4
    wk-form4_1762828151.xmlPrimary

    FORM 4